AbbVie Inc. — Director's Dealing 2018

Dec 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-12-13

Reporting Person: Schumacher Laura J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-13	Common stock, $0.01 par value	A	112530	—	Acquired	210788	Direct
2018-12-13	Common stock, $0.01 par value	F	49852	$88.60	Disposed	160936	Direct

Footnotes

F1: Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2, above, upon certification by the Compensation Committee of AbbVie's Board of Directors of the achievement of specified strategic milestones.